{
  "input": {
    "mode": "report_and_evolve",
    "query": {
      "entity": "Atypical haemolytic uraemic syndrome",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_eculizumab",
          "name": "Eculizumab"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_ravulizumab",
          "name": "Ravulizumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_plasma_exchange",
          "name": "Plasma exchange"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_tacrolimus",
          "name": "Tacrolimus"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_antithrombin_iii",
          "name": "Antithrombin III"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_cangrelor",
          "name": "Cangrelor"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_sirolimus",
          "name": "Sirolimus"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_lenalidomide",
          "name": "Lenalidomide"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_aspirin",
          "name": "Aspirin"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "scores": [],
    "ranking": [],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_plasma_exchange",
          "type": "Drug",
          "label": "Plasma exchange",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tacrolimus",
          "type": "Drug",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_antithrombin_iii",
          "type": "Drug",
          "label": "Antithrombin III",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cangrelor",
          "type": "Drug",
          "label": "Cangrelor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sirolimus",
          "type": "Drug",
          "label": "Sirolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_lenalidomide",
          "type": "Drug",
          "label": "Lenalidomide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_aspirin",
          "type": "Drug",
          "label": "Aspirin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_complement_system",
          "type": "Target",
          "label": "Complement system",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_inflammatory_response",
          "type": "Pathway",
          "label": "Inflammatory response",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_atypical_haemolytic_uraemic_syndrome",
          "type": "Disease",
          "label": "Atypical Haemolytic Uraemic Syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_plasma_exchange",
          "type": "Treatment",
          "label": "Plasma exchange",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_tacrolimus",
          "type": "Drug",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_antithrombin_iii",
          "type": "Drug",
          "label": "Antithrombin III",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_cangrelor",
          "type": "Drug",
          "label": "Cangrelor",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_sirolimus",
          "type": "Drug",
          "label": "Sirolimus",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_lenalidomide",
          "type": "Drug",
          "label": "Lenalidomide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_aspirin",
          "type": "Drug",
          "label": "Aspirin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot",
          "type": "Target",
          "label": "OffTarget",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp",
          "type": "Pathway",
          "label": "RiskPathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv",
          "type": "Phenotype",
          "label": "AdverseEffect",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Eculizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Plasma exchange",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Rituximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Antithrombin III",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Cangrelor",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Sirolimus",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Lenalidomide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Aspirin",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_eculizumab",
          "target": "target_complement_system",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知作用于补体系统的药物"
        },
        {
          "source": "drug_ravulizumab",
          "target": "target_complement_system",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与Eculizumab类似，抑制补体活化"
        },
        {
          "source": "drug_plasma_exchange",
          "target": "pathway_inflammatory_response",
          "relation": "involved_in",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "通过去除致病因子影响炎症反应"
        },
        {
          "source": "drug_corticosteroids",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "常用于调节炎症反应"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "可影响免疫和炎症反应"
        },
        {
          "source": "drug_tacrolimus",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "调节免疫反应，潜在影响炎症"
        },
        {
          "source": "drug_rituximab",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "通过靶向B细胞抑制炎症"
        },
        {
          "source": "drug_antithrombin_iii",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "与炎症和血栓形成的关系"
        },
        {
          "source": "drug_cangrelor",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "影响血小板活性与炎症反应"
        },
        {
          "source": "drug_sirolimus",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "通过免疫抑制影响炎症"
        },
        {
          "source": "drug_lenalidomide",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "有潜在的抗炎特性"
        },
        {
          "source": "drug_aspirin",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "抗炎与止血作用"
        },
        {
          "source": "target_complement_system",
          "target": "disease_atypical_haemolytic_uraemic_syndrome",
          "relation": "involved_in",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "补体系统在该疾病发病机制中起关键作用"
        },
        {
          "source": "pathway_inflammatory_response",
          "target": "disease_atypical_haemolytic_uraemic_syndrome",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "炎症反应与该疾病相关"
        },
        {
          "source": "n_eculizumab",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能干预非靶效应"
        },
        {
          "source": "n_ravulizumab",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能干预非靶效应"
        },
        {
          "source": "n_plasma_exchange",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_corticosteroids",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "可能诱发副作用通路"
        },
        {
          "source": "n_cyclophosphamide",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "可能诱发副作用通路"
        },
        {
          "source": "n_tacrolimus",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "可能诱发副作用通路"
        },
        {
          "source": "n_rituximab",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "可能诱发副作用通路"
        },
        {
          "source": "n_antithrombin_iii",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "可能诱发副作用通路"
        },
        {
          "source": "n_cangrelor",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "可能诱发副作用通路"
        },
        {
          "source": "n_sirolimus",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "可能诱发副作用通路"
        },
        {
          "source": "n_lenalidomide",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "可能诱发副作用通路"
        },
        {
          "source": "n_aspirin",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "可能诱发副作用通路"
        },
        {
          "source": "n_ot",
          "target": "n_rp",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "可能导致不良表型"
        },
        {
          "source": "n_adv",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若副作用链成立，将抵消疗效"
        },
        {
          "source": "n_adv",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若副作用链成立，将抵消疗效"
        },
        {
          "source": "n_adv",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若副作用链成立，将抵消疗效"
        },
        {
          "source": "n_adv",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若副作用链成立，将抵消疗效"
        },
        {
          "source": "n_adv",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若副作用链成立，将抵消疗效"
        },
        {
          "source": "n_adv",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若副作用链成立，将抵消疗效"
        },
        {
          "source": "n_adv",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若副作用链成立，将抵消疗效"
        },
        {
          "source": "n_adv",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若副作用链成立，将抵消疗效"
        },
        {
          "source": "n_adv",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若副作用链成立，将抵消疗效"
        },
        {
          "source": "n_adv",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若副作用链成立，将抵消疗效"
        },
        {
          "source": "n_adv",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若副作用链成立，将抵消疗效"
        },
        {
          "source": "n_adv",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若副作用链成立，将抵消疗效"
        }
      ],
      "round_index": 2
    },
    "history": {
      "round": 2
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_eculizumab",
          "name": "Eculizumab"
        },
        "score": 0.76,
        "graph_snapshot_ref": "GE_H1_round2",
        "key_assumptions": [
          "Eculizumab有效抑制补体系统，改善疾病进程",
          "补体系统与病理机制核心相关，减少炎症反应"
        ],
        "caveats": [
          "如果长期使用可能导致的副作用未被充分评估"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_ravulizumab",
          "name": "Ravulizumab"
        },
        "score": 0.75,
        "graph_snapshot_ref": "GE_H2_round2",
        "key_assumptions": [
          "Ravulizumab同样抑制补体活化，预期效果类似于Eculizumab"
        ],
        "caveats": [
          "潜在未评估的长效安全性与疗效"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_plasma_exchange",
          "name": "Plasma exchange"
        },
        "score": 0.72,
        "graph_snapshot_ref": "GE_H3_round2",
        "key_assumptions": [
          "通过去除致病因子，能有效改善症状"
        ],
        "caveats": [
          "需澄清长期结果与可能的风险"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→Target_complement_system→Disease_atypical_haemolytic_uraemic_syndrome",
          "reason": "直接针对补体系统，符合疾病机制"
        }
      ],
      "remaining_gaps": [
        "疗效被副作用所抵消的风险仍需重点讨论",
        "需加强对替代疗法的讨论与比较"
      ]
    },
    "seed_retrospective": {
      "batches": [
        {
          "round": 1,
          "seeds": [
            "A",
            "B",
            "C",
            "D"
          ],
          "impact_summary": "补充了补体系统相关药物，显著提升了潜在治疗选项的多样性"
        },
        {
          "round": 2,
          "seeds": [
            "E",
            "F"
          ],
          "impact_summary": "仍存在一些安全性方面的未解之题，需要后续评估"
        }
      ],
      "lessons": [
        "对于安全性未充分评估的药物，应优先提供替代方案的比较",
        "理解与疾病机制相关的各类药物作用路径至关重要"
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "评估各类药物的疗效与副作用，确保风险与收益的权衡"
      },
      {
        "role": "Skeptic",
        "patch": "指出副作用与药物疗效之间的可能冲突，并要求进一步的实验验证"
      },
      {
        "role": "Explorer",
        "patch": "保持与疾病机制相关的药物和疗法信息的更新与补充"
      }
    ],
    "heuristics": [
      {
        "when": "针对补体系统的治疗",
        "then": "评估疗效与副作用之间的平衡，特别是在长期使用时"
      },
      {
        "when": "考虑慢性疾病管理",
        "then": "需探讨多种医疗方案的综合效果"
      }
    ]
  }
}